Celcuity
CELC
40 hedge funds and large institutions have $124M invested in Celcuity in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
5% more funds holding
Funds holding: 38 → 40 (+2)
16.64% less ownership
Funds ownership: 72.33% → 55.69% (-17%)
21% less capital invested
Capital invested by funds: $156M → $124M (-$32.5M)
34% less call options, than puts
Call options by funds: $72K | Put options by funds: $109K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.24M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.11M |
| 3 |
Morgan Stanley
New York
|
+$2.55M |
| 4 |
BlackRock
New York
|
+$919K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$850K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.4M |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$666K |
| 3 |
Millennium Management
New York
|
-$530K |
| 4 |
SFG
SNS Financial Group
Minneapolis,
Minnesota
|
-$190K |
| 5 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
-$54.8K |
CELC Hedge Fund Activity: Q1 2023 in Review
40 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Celcuity (CELC) for Q1 2023, worth a combined $124M — down 21% from $156M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CELC positions and 4 closed out — a net gain of 2 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $5.24M. The largest seller was PFM Health Sciences, cutting an estimated $4.4M.
- 40 institutional investors held Celcuity (CELC) as of Q1 2023, up from 38 in Q4 2022.
- Funds reported $124M of Celcuity stock for Q1 2023, down 21% quarter-over-quarter.
- 6 funds opened new Celcuity positions in Q1 2023 and 4 closed out, a net change of +2 holders.
- The largest Celcuity buyer in Q1 2023 was Soleus Capital Management, an estimated $5.24M added.
- The largest Celcuity seller in Q1 2023 was PFM Health Sciences, an estimated $4.4M sold.
Based on aggregated 13F filings for Q1 2023.